Skip to content

CIK 0000001800

ABT ABBOTT LABORATORIES

Insider trading from SEC Form 4. Last filing Oct 23, 2024.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
1
with a Form 4 at this company

Signals

Open-market buys and sells at ABBOTT LABORATORIES, scored.

ScoreSideInsiderValueSharesHoldings changePrice contextFiled
15Weaksell10b5-1ALLEN HUBERT L
EXECUTIVE VICE PRESIDENT
$18M157,421-46%-

Congressional trades

32 trades in ABT disclosed by members of Congress under the STOCK Act, the newest 20 shown. All congressional trades.

MemberTypeAssetAmountTradedFiled
Gilbert Ray Cisneros, Jr.
House · D-CA
Partial saleABT
Abbott Laboratories Common Stock
$1,001 to $15kFeb 10, 2026
27 days after the trade
Thomas H. Kean, Jr.
House · R-NJ
PurchaseABT
Abbott Laboratories Common Stock
$1,001 to $15kJan 29, 2026
21 days after the trade
Julie Johnson
House · D-TX
SaleABT
Abbott Laboratories Common Stock
$1,001 to $15kDec 18, 2025
28 days after the trade
Julia Letlow
House · R-LA
PurchaseABT
Abbott Laboratories Common Stock
$1,001 to $15kOct 23, 2024
447 days after the trade
Julia Letlow
House · R-LA
SaleABT
Abbott Laboratories Common Stock
$1,001 to $15kDec 8, 2025
36 days after the trade
Gilbert Ray Cisneros, Jr.
House · D-CA
Partial saleABT
Abbott Laboratories Common Stock
$1,001 to $15kDec 19, 2025
24 days after the trade
Byron Donalds
House · R-FL
SaleABT
Abbott Laboratories Common Stock
$1,001 to $15kDec 4, 2025
34 days after the trade
Byron Donalds
House · R-FL
SaleABT
Abbott Laboratories Common Stock
$1,001 to $15kDec 4, 2025
34 days after the trade
Gilbert Ray Cisneros, Jr.
House · D-CA
PurchaseABT
Abbott Laboratories Common Stock
$1,001 to $15kNov 18, 2025
27 days after the trade
Julie Johnson
House · D-TX
Partial saleABT
Abbott Laboratories Common Stock
$1,001 to $15kNov 13, 2025
28 days after the trade
Richard McCormick
House · R-GA
PurchaseABT
Abbott Laboratories Common Stock
$1,001 to $15kNov 5, 2025
34 days after the trade
Rick Larsen
House · D-WA
PurchaseABT
Abbott Laboratories Common Stock
$1,001 to $15kOct 6, 2025
10 days after the trade
Richard McCormick
House · R-GA
PurchaseABT
Abbott Laboratories Common Stock
$1,001 to $15kMar 15, 2023
917 days after the trade
Julie Johnson
House · D-TX
Partial saleABT
Abbott Laboratories Common Stock
$1,001 to $15kAug 14, 2025
28 days after the trade
Thomas H. Kean, Jr.
House · R-NJ
PurchaseABT
Abbott Laboratories Common Stock
$1,001 to $15kJul 21, 2025
30 days after the trade
Lisa C. McClain
House · R-MI
SaleABT
Abbott Laboratories Common Stock
$1,001 to $15kJul 10, 2025
34 days after the trade
Lisa C. McClain
House · R-MI
PurchaseABT
Abbott Laboratories Common Stock
$1,001 to $15kJun 24, 2025
50 days after the trade
Josh Gottheimer
House · D-NJ
Partial saleABT
Abbott Laboratories Common Stock
$1,001 to $15kJul 18, 2025
24 days after the trade
Jefferson Shreve
House · R-IN
SaleABT
Abbott Laboratories Common Stock
$50k to $100kMay 12, 2025
41 days after the trade
Bruce Westerman
House · R-AR
SaleABT
Abbott Laboratories Common Stock
$1,001 to $15kApr 21, 2025
21 days after the trade

Transactions

The last 5 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 21, 2024ALLEN HUBERT L
EXECUTIVE VICE PRESIDENT
MOption exercise
Common shares without par value10b5-1
+157,421$47.00$7.4M342,227Oct 23, 2024
Oct 21, 2024ALLEN HUBERT L
EXECUTIVE VICE PRESIDENT
SOpen-market sale
Common shares without par value10b5-1
-1,249$118.81$148k340,978Oct 23, 2024
Oct 21, 2024ALLEN HUBERT L
EXECUTIVE VICE PRESIDENT
SOpen-market sale
Common shares without par value10b5-1
-5,901$118.15$697k335,077Oct 23, 2024
Oct 21, 2024ALLEN HUBERT L
EXECUTIVE VICE PRESIDENT
SOpen-market sale
Common shares without par value10b5-1
-150,271$116.98$18M184,806Oct 23, 2024
Oct 21, 2024ALLEN HUBERT L
EXECUTIVE VICE PRESIDENT
MOption exercise
Option (right to buy)derivative10b5-1
-157,421$0.00$00Oct 23, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.